For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are twelve…
Source
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in France. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in France? Read Post »
Annual Drug Patent Expirations for TYVASO+DPI Tyvaso Dpi is a drug marketed by United Therap and is included in one NDA. It is available from one supplier. There are eight…
Source
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
Source
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for…
Source
New tentative approval for Sandoz Inc drug rifaximin Read Post »
Annual Drug Patent Expirations for TYVASO Tyvaso is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are eleven patents…
Source
Annual Drug Patent Expirations for SYFOVRE Syfovre is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are ten patents…
Source
This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in France? Read Post »